Shareholders' Meeting

Reforma Newspaper

Informador Newspaper

Secretaría de Economía

Guadalajara, Jalisco, Mexico, February 25, 2022 – Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announced the following:

Pursuant to a resolution adopted by our Board of Directors on February 22, 2022, and in accordance with Articles 180, 181, 182 and other applicable articles of the Mexican General Corporations Law and Article 35 of the Company’s by-laws, GAP invites its shareholders to the General Ordinary and General Extraordinary Shareholders’ Meeting on April 22, 2022 at 12:00 and 2:00 pm, respectively, in Salon Midtown Ballroom 3, 3^rd floor  of the Hilton Hotel, located at Av. López Mateos 2405-300, Col. Italia Providencia , Guadalajara, Jalisco, Mexico, to discuss the following:

ANNUAL GENERAL ORDINARY SHAREHOLDERS’ MEETING

AGENDA

1. I. In compliance with Article 28, Section IV of the Mexican Securities Market Law, the following will be presented and, if applicable, submitted for approval:

1. a. The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2021, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company on an unconsolidated basis in accordance with Mexican Financial Reporting Standards (“MFRS”), as well as with respect to the Company and its subsidiaries on a consolidated basis in accordance with International Financial Reporting Standards (“IFRS”), each based on the Company’s most recent financial statements for the fiscal year ended December 31, 2021, under both standards, as well as the 2021 Sustainability Report.

1. b. Board of Directors’ opinion to the Chief Executive Officer’s report.

1. c. Board of Directors’ report in accordance with Article 172, clause b, of the Mexican General Corporations Law, regarding the Company’s main accounting policies and criteria, as well as the information used to prepare the Company’s financial statements.

1. d .Report on transactions and activities undertaken by the Company’s Board of Directors during the fiscal year ended December 31, 2021, pursuant to the Mexican Securities Market Law.

1. e. The annual report on the activities undertaken by the Audit and Corporate Practices Committee in accordance with Article 43 of the Mexican Securities Market Law, as well as the ratification of the actions of the various committees, and release from further obligations.

1. f. Report on the Company’s compliance with tax obligations for the fiscal year from January 1 to December 31, 2020, and an instruction to Company officials to comply with tax obligations corresponding to the fiscal year from January 1 and ended December 31, 2021, in accordance with Article 26, Section III of the Mexican Fiscal Code.

1. II. As a result of the reports in item I above, ratification of the actions of our Board of Directors and officers and release from further obligations in the fulfillment of their duties.

III. Presentation, discussion and submission for approval of the Company’s financial statements for the fiscal year from January 1 to December 31, 2021, on an unconsolidated basis, in accordance with MFRS for purposes of calculating legal reserves, net income, fiscal effects related to dividend payments and capital reduction, as applicable, and approval of the financial statements of the Company and its subsidiaries on a consolidated basis in accordance with IFRS for their publication to financial markets, with respect to our operations that took place during the fiscal year from January 1 to December 31, 2021; and approval of the external auditor’s report regarding both aforementioned financial statements.

Individual

Consolidated

1. IV. Proposal to approve from the Company’s net income for the fiscal year ended December 31, 2021, reported in its unconsolidated financial statements, presented in agenda item III above and audited in accordance with MFRS, which was Ps. 5,811,099,785.00 (FIVE BILLION EIGHT HUNDRED ELEVEN MILLION NINETY-NINE THOUSAND SEVEN HUNDRED EIGHTY-FIVE PESOS 00/100 M.N.), the allocation of the entire amount towards increasing the Company’s retained earnings account, without separating an amount for the Company’s legal reserves, given that the account currently represents more than 20% of the historical common stock of the Company, thereby meeting the requirement established in Article 20 of the Mexican General Corporations Law. In addition, proposal to cancel from the Company’s current legal reserves such amount exceeding 20% of the historical common stock of the Company, in accordance with the requirements established in Articles 20 and 21 of the Mexican General Corporations Law and allocating said excess amount to the Company’s retained earnings account.

1. V. Presentation, discussion and submission for approval that from the retained earnings account pending application which amounts to a total of Ps. 10,529,179,720.00 (TEN BILLION FIVE HUNDRED TWENTY-NINE MILLION ONE HUNDRED AND SEVENTY-NINE THOUSAND SEVEN HUNDRED AND TWENTY PESOS 00/100 M.N.), a dividend be declared equal to $14.40 (FOURTEEN PESOS 40/100 M.N.) pesos per share, to be paid to the holders of each share outstanding on the payment date, excluding any shares repurchased by the Company in accordance with Article 56 of the Mexican Securities Market Law; any amounts of retained earnings pending application remaining after the payment of such dividend will remain in the retained earnings account pending application. The dividend will be payable in one or more installments within 12 (twelve) months after April 22, 2022.

1. VI. Cancellation of any amounts outstanding, as of the date of the General Ordinary Shareholders’ Meeting, under the Share Repurchase Program approved at the General Ordinary Shareholders’ Meetings that took place on April 27, 2021 and September 14, 2021, and proposal to approve Ps. 2,000,000,000.00 (TWO BILLION PESOS 00/100 M.N.) as the maximum amount to be allocated toward the repurchase of the Company’s shares or credit instruments that represent such shares for the 12-month period following April 22, 2022, in accordance with Article 56, Section IV of the Mexican Securities Market Law.

1. VII. The report regarding the designation or ratification of the four members of the Board of Directors and their respective alternates appointed by the Series BB shareholders.

1. VIII. Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by any holder or group of holders of Series B shares that owns, individually or collectively, 10% or more of the Company’s common stock.

1. IX. Ratification and/or designation of the persons that will serve as members of the Company’s Board of Directors, as designated by the Series B shareholders and certification of independence.

1. a) Ratification of Carlos Cárdenas Guzmán (independence letter)
2. b) Ratification of Ángel Losada Moreno (independence letter)
3. c) Ratification of Joaquín Vargas Guajardo (indepedence letter)
4. d) Ratification of Juan Diez-Canedo Ruíz (independence letter)
5. e) Ratification of Álvaro Fernández Garza (independence letter)
6. f) Ratification of Luis Tellez Kuenzler (independence letter)
7. g) Designation of Alejandra Palacios Prieto (independence letter)

1. X. Ratification and/or designation of the Chairman of the Company’s Board of Directors, in accordance with Article 16 of the Company’s by-laws.

1. XI. Ratification of the compensation paid to the members of the Company’s Board of Directors during the 2021 fiscal year and determination of the compensation to be paid in 2022.

1. XII. Ratification and/or designation of the member of our Board of Directors designated by the Series B shareholders to serve as a member of the Company’s Nominations and Compensation Committee, in accordance with Article 28 of the Company’s bylaws.

1. XIII. Ratification and/or designation of the President of the Audit and Corporate Practices Committee.

1. XIV. The report concerning compliance with Article 29 of the Company’s bylaws regarding acquisitions of goods or services or contracting of projects or asset sales that are equal to or greater than US$ 3,000,000.00 (THREE MILLION U.S. DOLLARS), or its equivalent in Mexican pesos or other legal tender in circulation outside Mexico, or, if applicable, regarding transactions with relevant shareholders.

1. XV. Presentation of our Public Objectives for environmental, social responsibility and corporate governance of the Company for the year 2030.

1. XVI. Appointment and designation of special delegates to appear before a public notary and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.

EXTRAORDINARY SHAREHOLDERS’ MEETING

 AGENDA

1. I. Discussion and submission for approval of an increase in the Company's Common Stock, through the capitalization of the "Restatement effect of Common Stock" account, as recorded in the Company's unconsolidated financial statements as of December 31, 2021, in the amount of Ps. 8,027,154,754.00 (EIGHT BILLION TWENTY-SEVEN MILLION ONE HUNDRED AND FIFTY-FOUR THOUSAND SEVEN HUNDRED AND FIFTY-FOUR PESOS 00/100 M.N.).

1. II. Proposal to approve the cancellation the Company’s shares that have been repurchased and are, as of the date of the Extraordinary Shareholders’ Meeting,held in the Company’s treasury.

1. III. Perform all corporate legal formalities required, including the amendment of Article 6 of the Company’s by-laws, derived from the adoption of resolutions at this shareholders’ meeting.

1. IV. Appointment and designation of special delegates to appear before a public notary and present the resolutions adopted at this meeting for formalization. Adoption of the resolutions deemed necessary or convenient in order to fulfill the decisions adopted in relation to the preceding agenda items.

Shareholders are reminded that in accordance with Article 36 of the Company’s by-laws, only those shareholders registered in the Company’s share registry as holders of one or more of the Company’s shares will be admitted into the shareholders’ meetings, and they will be admitted only if they have obtained an admission card. The share registry will close three (3) business days prior to the date of this meeting.

In order to attend the meeting, at least one (1) business day prior to the meeting: (i) shareholders must deposit with the Company their stock certificates, shares or a receipt of deposit of shares from S.D. Indeval Institución para el Depósito de Valores, S.A. de C.V. (“Indeval”) or from a local or foreign financial institution, and (ii) brokerage firms and other depositors at Indeval should present a listing containing the name, address, nationality and number of shares of the shareholders they will represent at the meeting.  In exchange for these documents, the Company will issue, in accordance with the Company’s bylaws, an admission card and/or the forms required under Article 49, Section III of the Mexican Securities Market Law in order to be represented.  In order to attend the meeting, shareholders must present the admission card and/or the corresponding form.

Shares deposited in order to gain admittance to these meetings will only be returned, via a voucher that will have been given to the shareholder or his/her representative.

Shareholders may be represented by proxy at the meetings by any person designated by a power of attorney signed before two witnesses or as otherwise authorized by law. However, with respect to the Company’s common stock traded on a stock exchange, the proxy or proxies may only verify their identities via Company forms.  These will be available to all shareholders, including any stockbrokers, during the time period specified in Article 173 of the Mexican General Corporations Law.

Following the publication of this announcement, all shareholders and their legal representatives will have free and immediate access to all information and documents related to each of the topics included in the meeting agendas, as well as all proxy forms that must be presented by persons representing shareholders. These documents will be available at the Company’s offices located at Av. Mariano Otero #1249-B, 6^th Floor, Col. Rinconada del Bosque, Guadalajara, Jalisco 44530 or at Arquímedes #19, 4^th Floor, Col. Bosque de Chapultepec, C.P. 11580, Alcaldía Miguel Hidalgo, Mexico City, Mexico 11580. 

Shareholders are invited to contact the Company should they have need for any additional information. 

                                                                                                   * * *